pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
2025 predictions and AI trends for pharma executives
7 hours ago · Amy Brown is the founder and CEO of Authenticx, a software platform that analyses and activates patients’ voices at scale to reveal transformational opportunities in healthcare.
News | Timely industry updates for pharma and biotech leaders
2 days ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Life Sciences Industry Report 2025 | pharmaphorum
Jan 9, 2025 · In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024.
11 blockbuster drugs to look out for in 2025 | pharmaphorum
2 days ago · Clarivate has revealed 11 drugs due to launch in 2025 that could top $1 billion in annual sales or be clinical 'game changers' in the next five years.
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, Research Partnership, PurpleLeaf Strategy, M3, and more
Heard on the pipeline: Access to medication - pharmaphorum
Solving the challenge of access to medication has fuelled many a debate among healthcare stakeholders over the years. Yet, while discussions have been plentiful, even fruitful, patients around the world still struggle to access treatments.
Cassava’s Alzheimer’s drug nears P3 readout, but SEC scandal …
Nov 6, 2024 · Cassava Sciences is nearing a Phase 3 readout for its Alzheimer's drug, lecanemab, despite facing a scandal involving the SEC. Learn more about the latest updates on donanemab and the company's ...
The biopharma outlook for 2025: Opportunities and challenges
Jan 8, 2025 · With the Federal Reserve poised to implement interest rate cuts (albeit fewer than earlier forecasts assumed) and FTC leadership turnover anticipated, there may be broader shifts in how capital is ...
Deep Dive | A bimonthly magazine for in-depth pharma stories
pharmaphorum presents a bimonthly Deep Dive magazine with extended, visually appealing features on R&D, patients, market access, digital health, and more.